Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Matrix Capital Management Company, LP

At a glance: Matrix Capital Management Company, LP is 10% Owner at Aura Biosciences (AURA). Their latest SEC Form 4, filed May 11, 2026, reported a sale of $39.0M. On file: 0 purchase lines ($0) and 1 sale line ($39.0M).

10% Owner at Aura Biosciences, Inc. (AURA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $39.0M

Matrix Capital Management Company, LP's InsiderPrint

4 trades from SEC Form 4 filings, 2022 to 2026, drawn as one fingerprint.

InsiderPrint of Matrix Capital Management Company, LP: 4 trades, 2022 to 20262022: 1 buy, 0 sales2023: 2 buys, 0 sales2024: 0 buys, 0 sales2025: 0 buys, 0 sales2026: 0 buys, 1 sale

Reading this print: Mostly buys, trading about once a year, typically $39.0M a trade.

  • Bump outward: a purchase (3)
  • Dent inward: a sale (1)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Jay L. SchottensteinCEO, Chair · AEO · 98% matchTheir buys since 2020: 1 of 4 beat the S&P 500
  2. Roivant Sciences Ltd.Director · IMVT · 98% match
  3. Elon MuskCEO, CTO · SPCX · 97% match
  4. John G. DanhaklDirector · LTH · 96% match
  5. Oxford Science Enterprises PLCFormer 10% Owner · PEPG · 96% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Every purchase since 2022

From the SEC's insider data sets: each open-market buy by Matrix Capital Management Company, LP, matched to how the stock did over the next 90 days against the S&P 500.

0 of 2 buys beat the S&P 500 (0%), median -8.2% vs. the index. Small sample: treat with care. All insider buys: 46%.

StockFiled90 days vs. S&P 500
AURANov 9, 2023-1.3%
AURADec 15, 2022-15.2%

Buys made close together in one stock count once. Price-only returns; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
May 11SEC AURAAura Biosciences, Inc. Sell 6,922,870 $5.64 $39.0M +22.3%

Follow Matrix Capital Management Company, LP

Get one email when Matrix Capital Management Company, LP files a new purchase or sale. Free.

At most one email a day about Matrix Capital Management Company, LP, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.